+91-22-48913909
ഫിൻ‌കാഷ് »മ്യൂച്വൽ ഫണ്ടുകൾ »മികച്ച പ്രകടനം നടത്തുന്ന ഇക്വിറ്റി ഫണ്ടുകൾ 2018
Table of Contents
2019 ലെ മികച്ച ഇക്വിറ്റി മ്യൂച്വൽ ഫണ്ടുകൾ
ഇക്വിറ്റി ഫണ്ടുകൾ വിവിധ കമ്പനികളുടെ ഇക്വിറ്റി, ഇക്വിറ്റി സംബന്ധിയായ ഉപകരണങ്ങളിൽ നിക്ഷേപിച്ച ഫണ്ട് പണം നിക്ഷേപിക്കുന്നവരാണ്. മിതമായതും ഉയർന്നതുമായ ആളുകൾക്ക് ദീർഘകാല നിക്ഷേപ ഓപ്ഷനായി ഇക്വിറ്റി ഫണ്ടുകൾ കണക്കാക്കപ്പെടുന്നുഅപകടസാധ്യത വിശപ്പ്. ഇക്വിറ്റി ഫണ്ടുകളുടെ വിവിധ വിഭാഗങ്ങൾ ഉൾപ്പെടുന്നുവലിയ ക്യാപ് ഫണ്ടുകൾ,മിഡ് ക്യാപ് ഫണ്ടുകൾ,ചെറിയ ക്യാപ് ഫണ്ടുകൾ,ELSS, ഇത്യാദി. 2019 ൽ, ഇക്വിറ്റി മാർക്കറ്റുകളിൽ ഒരു ഉയർച്ചയുണ്ടായി, ഇക്വിറ്റി ഫണ്ട് വിഭാഗങ്ങളിൽ ഭൂരിഭാഗവും മികച്ച പ്രകടനം കാഴ്ചവച്ചു. ഈ ഫണ്ടുകളുടെ പ്രകടനം വ്യവസായ പ്രകടനം, കമ്പനി പ്രകടനം, കമ്പനികളുടെ വരുമാനവും ലാഭവും, അതിന്റെ ഭാവി സാധ്യതകൾ തുടങ്ങിയ നിരവധി മാക്രോ, മൈക്രോ ഇക്കണോമിക് പാരാമീറ്ററുകളെ ആശ്രയിച്ചിരിക്കുന്നു. മുകളിലുംമികച്ച ഇക്വിറ്റി ഫണ്ടുകൾ 2019 വർഷത്തിൽ ഇനിപ്പറയുന്നവയാണ്.
Talk to our investment specialist
പ്രകടനത്തെ അടിസ്ഥാനമാക്കി 2019 ലെ മികച്ച 10 ഇക്വിറ്റി മ്യൂച്വൽ ഫണ്ടുകൾ
Fund NAV Net Assets (Cr) 2024 (%) 2023 (%) 2022 (%) 2021 (%) 2020 (%) Motilal Oswal Midcap 30 Fund Growth ₹88.6047
↓ -0.24 ₹24,488 57.1 41.7 10.7 55.8 9.3 LIC MF Infrastructure Fund Growth ₹40.7079
↓ -0.33 ₹881 47.8 44.4 7.9 46.6 -0.1 Motilal Oswal Long Term Equity Fund Growth ₹42.3137
↓ -0.16 ₹3,876 47.7 37 1.8 32.1 8.8 Motilal Oswal Multicap 35 Fund Growth ₹53.8796
↓ -0.15 ₹11,855 45.7 31 -3 15.3 10.3 Invesco India Mid Cap Fund Growth ₹142.37
↓ -0.84 ₹5,645 43.1 34.1 0.5 43.1 24.4 UTI Healthcare Fund Growth ₹255.525
↓ -0.59 ₹1,150 42.9 38.2 -12.3 19.1 67.4 SBI Healthcare Opportunities Fund Growth ₹394.43
↓ -0.17 ₹3,522 42.2 38.2 -6 20.1 65.8 TATA India Pharma & Healthcare Fund Growth ₹27.3567
↓ -0.11 ₹1,212 40.4 36.6 -8 19.1 64.4 IDBI Small Cap Fund Growth ₹26.2569
↓ -0.06 ₹491 40 33.4 2.4 64.7 19 L&T Midcap Fund Growth ₹312.188
↓ -1.64 ₹10,753 39.7 40 1.1 30.4 19 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 13 Mar 25
2019 ലെ മികച്ചതും മികച്ചതുമായ ഇക്വിറ്റി മ്യൂച്വൽ ഫണ്ടുകൾ
(Erstwhile Motilal Oswal MOSt Focused Midcap 30 Fund) The investment objective of the Scheme is to achieve long term capital appreciation by investing in a maximum of 30 quality mid-cap companies having long-term competitive advantages and potential for growth. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Motilal Oswal Midcap 30 Fund is a Equity - Mid Cap fund was launched on 24 Feb 14. It is a fund with Moderately High risk and has given a Below is the key information for Motilal Oswal Midcap 30 Fund Returns up to 1 year are on The investment objective of the scheme is to provide long term growth from a portfolio of equity / equity related instruments of companies engaged either directly or indirectly in the infrastructure sector. LIC MF Infrastructure Fund is a Equity - Sectoral fund was launched on 29 Feb 08. It is a fund with High risk and has given a Below is the key information for LIC MF Infrastructure Fund Returns up to 1 year are on (Erstwhile Motilal Oswal MOSt Focused Long Term Fund) The investment objective of the Scheme is to generate long-term capital appreciation from a diversified portfolio of predominantly equity and equity related instruments. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Motilal Oswal Long Term Equity Fund is a Equity - ELSS fund was launched on 21 Jan 15. It is a fund with Moderately High risk and has given a Below is the key information for Motilal Oswal Long Term Equity Fund Returns up to 1 year are on (Erstwhile Motilal Oswal MOSt Focused Multicap 35 Fund) The investment objective of the Scheme is to achieve long term capital appreciation by primarily investing in a maximum of 35 equity & equity related instruments across sectors and market-capitalization levels.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Motilal Oswal Multicap 35 Fund is a Equity - Multi Cap fund was launched on 28 Apr 14. It is a fund with Moderately High risk and has given a Below is the key information for Motilal Oswal Multicap 35 Fund Returns up to 1 year are on The Scheme seeks to provide long term capital appreciation by investing in a portfolio that is predominantly constituted of equity and equity related instruments of mid cap companies. However, there can be no assurance that the funds objectives will be achieved. Invesco India Mid Cap Fund is a Equity - Mid Cap fund was launched on 19 Apr 07. It is a fund with Moderately High risk and has given a Below is the key information for Invesco India Mid Cap Fund Returns up to 1 year are on (Erstwhile UTI Pharma & Healthcare Fund) The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. UTI Healthcare Fund is a Equity - Sectoral fund was launched on 28 Jun 99. It is a fund with High risk and has given a Below is the key information for UTI Healthcare Fund Returns up to 1 year are on (Erstwhile SBI Pharma Fund) To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. SBI Healthcare Opportunities Fund is a Equity - Sectoral fund was launched on 31 Dec 04. It is a fund with High risk and has given a Below is the key information for SBI Healthcare Opportunities Fund Returns up to 1 year are on The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns. TATA India Pharma & Healthcare Fund is a Equity - Sectoral fund was launched on 28 Dec 15. It is a fund with High risk and has given a Below is the key information for TATA India Pharma & Healthcare Fund Returns up to 1 year are on The Investment objective of the Scheme is to provide investors with the opportunities for long-term capital appreciation by investing predominantly in Equity and Equity related instruments of Small Cap companies. However
there can be no assurance that the investment objective under the Scheme will be realized. IDBI Small Cap Fund is a Equity - Small Cap fund was launched on 21 Jun 17. It is a fund with Moderately High risk and has given a Below is the key information for IDBI Small Cap Fund Returns up to 1 year are on To generate capital appreciation by investing primarily in midcap stocks. The scheme will invest primarily in companies whose market capitalization falls between the highest and the lowest constituent of the Nifty Free Float Midcap 100. L&T Midcap Fund is a Equity - Mid Cap fund was launched on 9 Aug 04. It is a fund with High risk and has given a Below is the key information for L&T Midcap Fund Returns up to 1 year are on 1. Motilal Oswal Midcap 30 Fund
CAGR/Annualized return of 21.8% since its launch. Ranked 27 in Mid Cap category. Return for 2024 was 57.1% , 2023 was 41.7% and 2022 was 10.7% . Motilal Oswal Midcap 30 Fund
Growth Launch Date 24 Feb 14 NAV (13 Mar 25) ₹88.6047 ↓ -0.24 (-0.27 %) Net Assets (Cr) ₹24,488 on 31 Jan 25 Category Equity - Mid Cap AMC Motilal Oswal Asset Management Co. Ltd Rating ☆☆☆ Risk Moderately High Expense Ratio 0.66 Sharpe Ratio 0.93 Information Ratio 0.68 Alpha Ratio 15.2 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 29 Feb 20 ₹10,000 28 Feb 21 ₹11,725 28 Feb 22 ₹15,686 28 Feb 23 ₹18,295 29 Feb 24 ₹27,817 28 Feb 25 ₹32,165 Returns for Motilal Oswal Midcap 30 Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 13 Mar 25 Duration Returns 1 Month -4.9% 3 Month -22.2% 6 Month -17% 1 Year 18.1% 3 Year 27.5% 5 Year 29% 10 Year 15 Year Since launch 21.8% Historical performance (Yearly) on absolute basis
Year Returns 2024 57.1% 2023 41.7% 2022 10.7% 2021 55.8% 2020 9.3% 2019 9.7% 2018 -12.7% 2017 30.8% 2016 5.2% 2015 16.5% Fund Manager information for Motilal Oswal Midcap 30 Fund
Name Since Tenure Ajay Khandelwal 1 Oct 24 0.41 Yr. Niket Shah 1 Jul 20 4.67 Yr. Rakesh Shetty 22 Nov 22 2.27 Yr. Sunil Sawant 1 Jul 24 0.67 Yr. Data below for Motilal Oswal Midcap 30 Fund as on 31 Jan 25
Equity Sector Allocation
Sector Value Technology 34.2% Consumer Cyclical 16.45% Industrials 14.08% Health Care 4.4% Communication Services 3.36% Utility 2.23% Real Estate 1.95% Financial Services 1.73% Asset Allocation
Asset Class Value Cash 24.38% Equity 75.62% Top Securities Holdings / Portfolio
Name Holding Value Quantity Persistent Systems Ltd (Technology)
Equity, Since 31 Jan 23 | PERSISTENT10% ₹2,413 Cr 4,000,000
↑ 750,000 Coforge Ltd (Technology)
Equity, Since 31 Mar 23 | COFORGE10% ₹2,355 Cr 2,850,000
↑ 155,000 Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 29 Feb 24 | KALYANKJIL7% ₹1,761 Cr 35,000,100
↑ 1,750,100 Trent Ltd (Consumer Cyclical)
Equity, Since 30 Nov 24 | 5002516% ₹1,507 Cr 2,620,200
↓ -379,800 Dixon Technologies (India) Ltd (Technology)
Equity, Since 31 Mar 23 | DIXON6% ₹1,499 Cr 1,000,000
↑ 700,130 Polycab India Ltd (Industrials)
Equity, Since 30 Sep 23 | POLYCAB5% ₹1,117 Cr 1,850,000
↓ -1,400,000 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 24 | MAXHEALTH3% ₹855 Cr 8,056,130
↑ 556,130 Bharti Hexacom Ltd (Communication Services)
Equity, Since 31 Oct 24 | BHARTIHEXA3% ₹823 Cr 6,075,571
↑ 816,804 One97 Communications Ltd (Technology)
Equity, Since 30 Sep 24 | 5433963% ₹776 Cr 10,001,000
↑ 1,000 Oracle Financial Services Software Ltd (Technology)
Equity, Since 31 Dec 24 | OFSS3% ₹699 Cr 766,376
↓ -30,591 2. LIC MF Infrastructure Fund
CAGR/Annualized return of 8.6% since its launch. Return for 2024 was 47.8% , 2023 was 44.4% and 2022 was 7.9% . LIC MF Infrastructure Fund
Growth Launch Date 29 Feb 08 NAV (13 Mar 25) ₹40.7079 ↓ -0.33 (-0.81 %) Net Assets (Cr) ₹881 on 31 Jan 25 Category Equity - Sectoral AMC LIC Mutual Fund Asset Mgmt Co Ltd Rating Risk High Expense Ratio 2.3 Sharpe Ratio 0.83 Information Ratio 0.66 Alpha Ratio 16.19 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 29 Feb 20 ₹10,000 28 Feb 21 ₹12,107 28 Feb 22 ₹15,282 28 Feb 23 ₹16,314 29 Feb 24 ₹26,343 28 Feb 25 ₹27,309 Returns for LIC MF Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 13 Mar 25 Duration Returns 1 Month -4% 3 Month -22.8% 6 Month -21.6% 1 Year 16.9% 3 Year 24.1% 5 Year 26.5% 10 Year 15 Year Since launch 8.6% Historical performance (Yearly) on absolute basis
Year Returns 2024 47.8% 2023 44.4% 2022 7.9% 2021 46.6% 2020 -0.1% 2019 13.3% 2018 -14.6% 2017 42.2% 2016 -2.2% 2015 -6.2% Fund Manager information for LIC MF Infrastructure Fund
Name Since Tenure Yogesh Patil 18 Sep 20 4.45 Yr. Mahesh Bendre 1 Jul 24 0.66 Yr. Data below for LIC MF Infrastructure Fund as on 31 Jan 25
Equity Sector Allocation
Sector Value Industrials 53.89% Basic Materials 10.75% Consumer Cyclical 9.27% Utility 8.03% Financial Services 6.52% Technology 3.54% Real Estate 2.96% Communication Services 1.89% Energy 0.74% Asset Allocation
Asset Class Value Cash 1.84% Equity 98.16% Top Securities Holdings / Portfolio
Name Holding Value Quantity Shakti Pumps (India) Ltd (Industrials)
Equity, Since 31 Mar 24 | SHAKTIPUMP5% ₹42 Cr 447,229
↑ 56,077 Garware Hi-Tech Films Ltd (Basic Materials)
Equity, Since 31 Aug 23 | 5006554% ₹34 Cr 94,287
↑ 7,877 Tata Power Co Ltd (Utilities)
Equity, Since 29 Feb 24 | 5004003% ₹26 Cr 724,927
↑ 170,457 REC Ltd (Financial Services)
Equity, Since 31 Jul 23 | 5329553% ₹26 Cr 571,332
↑ 45,612 Carraro India Ltd (Consumer Cyclical)
Equity, Since 31 Dec 24 | CARRARO3% ₹25 Cr 426,422
↑ 116,563 Schneider Electric Infrastructure Ltd (Industrials)
Equity, Since 31 Dec 23 | SCHNEIDER3% ₹23 Cr 331,513
↑ 3,487 GE Vernova T&D India Ltd (Industrials)
Equity, Since 31 Jan 24 | 5222752% ₹22 Cr 121,339
↑ 1,276 Afcons Infrastructure Ltd (Industrials)
Equity, Since 31 Oct 24 | AFCONS2% ₹21 Cr 435,883
↑ 78,007 Bharat Heavy Electricals Ltd (Industrials)
Equity, Since 31 May 24 | 5001032% ₹20 Cr 983,002
↑ 144,733 Bharat Bijlee Ltd (Industrials)
Equity, Since 31 Jul 22 | BBL2% ₹20 Cr 61,351
↑ 2,120 3. Motilal Oswal Long Term Equity Fund
CAGR/Annualized return of 15.3% since its launch. Return for 2024 was 47.7% , 2023 was 37% and 2022 was 1.8% . Motilal Oswal Long Term Equity Fund
Growth Launch Date 21 Jan 15 NAV (13 Mar 25) ₹42.3137 ↓ -0.16 (-0.37 %) Net Assets (Cr) ₹3,876 on 31 Jan 25 Category Equity - ELSS AMC Motilal Oswal Asset Management Co. Ltd Rating Risk Moderately High Expense Ratio 0.74 Sharpe Ratio 0.74 Information Ratio 0.72 Alpha Ratio 10.73 Min Investment 500 Min SIP Investment 500 Exit Load NIL Growth of 10,000 investment over the years.
Date Value 29 Feb 20 ₹10,000 28 Feb 21 ₹11,796 28 Feb 22 ₹13,633 28 Feb 23 ₹14,395 29 Feb 24 ₹21,754 28 Feb 25 ₹22,281 Returns for Motilal Oswal Long Term Equity Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 13 Mar 25 Duration Returns 1 Month -6.3% 3 Month -24.9% 6 Month -22.4% 1 Year 11.1% 3 Year 20% 5 Year 20.7% 10 Year 15 Year Since launch 15.3% Historical performance (Yearly) on absolute basis
Year Returns 2024 47.7% 2023 37% 2022 1.8% 2021 32.1% 2020 8.8% 2019 13.2% 2018 -8.7% 2017 44% 2016 12.5% 2015 Fund Manager information for Motilal Oswal Long Term Equity Fund
Name Since Tenure Ajay Khandelwal 11 Dec 23 1.22 Yr. Rakesh Shetty 22 Nov 22 2.27 Yr. Atul Mehra 1 Oct 24 0.41 Yr. Data below for Motilal Oswal Long Term Equity Fund as on 31 Jan 25
Equity Sector Allocation
Sector Value Industrials 32.43% Consumer Cyclical 22.15% Financial Services 17.18% Technology 11.95% Real Estate 6.78% Basic Materials 6.03% Health Care 1.98% Asset Allocation
Asset Class Value Cash 1.51% Equity 98.49% Top Securities Holdings / Portfolio
Name Holding Value Quantity Trent Ltd (Consumer Cyclical)
Equity, Since 31 Aug 22 | 5002516% ₹245 Cr 425,260 Zomato Ltd (Consumer Cyclical)
Equity, Since 31 Oct 23 | 5433206% ₹219 Cr 9,923,692 Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 31 Oct 23 | KALYANKJIL4% ₹158 Cr 3,134,622 Amber Enterprises India Ltd Ordinary Shares (Consumer Cyclical)
Equity, Since 31 Mar 24 | AMBER4% ₹153 Cr 235,044 Gujarat Fluorochemicals Ltd Ordinary Shares (Basic Materials)
Equity, Since 28 Feb 23 | FLUOROCHEM4% ₹146 Cr 408,886 Prestige Estates Projects Ltd (Real Estate)
Equity, Since 31 Oct 23 | PRESTIGE4% ₹143 Cr 1,055,205 Kaynes Technology India Ltd (Industrials)
Equity, Since 30 Jun 23 | KAYNES4% ₹143 Cr 297,751 Suzlon Energy Ltd (Industrials)
Equity, Since 31 Jan 24 | SUZLON4% ₹140 Cr 24,068,813 Coforge Ltd (Technology)
Equity, Since 31 Jul 24 | COFORGE4% ₹139 Cr 168,355 Multi Commodity Exchange of India Ltd (Financial Services)
Equity, Since 29 Feb 24 | MCX3% ₹135 Cr 235,083 4. Motilal Oswal Multicap 35 Fund
CAGR/Annualized return of 16.8% since its launch. Ranked 5 in Multi Cap category. Return for 2024 was 45.7% , 2023 was 31% and 2022 was -3% . Motilal Oswal Multicap 35 Fund
Growth Launch Date 28 Apr 14 NAV (13 Mar 25) ₹53.8796 ↓ -0.15 (-0.27 %) Net Assets (Cr) ₹11,855 on 31 Jan 25 Category Equity - Multi Cap AMC Motilal Oswal Asset Management Co. Ltd Rating ☆☆☆☆☆ Risk Moderately High Expense Ratio 0.94 Sharpe Ratio 0.9 Information Ratio 0.49 Alpha Ratio 13.01 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 29 Feb 20 ₹10,000 28 Feb 21 ₹11,931 28 Feb 22 ₹12,199 28 Feb 23 ₹12,226 29 Feb 24 ₹18,009 28 Feb 25 ₹20,280 Returns for Motilal Oswal Multicap 35 Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 13 Mar 25 Duration Returns 1 Month -3.3% 3 Month -17.5% 6 Month -13.2% 1 Year 17.4% 3 Year 20.3% 5 Year 18.1% 10 Year 15 Year Since launch 16.8% Historical performance (Yearly) on absolute basis
Year Returns 2024 45.7% 2023 31% 2022 -3% 2021 15.3% 2020 10.3% 2019 7.9% 2018 -7.8% 2017 43.1% 2016 8.5% 2015 14.6% Fund Manager information for Motilal Oswal Multicap 35 Fund
Name Since Tenure Ajay Khandelwal 1 Oct 24 0.41 Yr. Niket Shah 1 Jul 22 2.67 Yr. Santosh Singh 1 Aug 23 1.58 Yr. Rakesh Shetty 22 Nov 22 2.27 Yr. Atul Mehra 1 Oct 24 0.41 Yr. Sunil Sawant 1 Jul 24 0.67 Yr. Data below for Motilal Oswal Multicap 35 Fund as on 31 Jan 25
Equity Sector Allocation
Sector Value Consumer Cyclical 22.53% Technology 21.94% Industrials 18.17% Financial Services 9.9% Communication Services 9.17% Health Care 1.79% Asset Allocation
Asset Class Value Cash 20.96% Equity 79.04% Top Securities Holdings / Portfolio
Name Holding Value Quantity Coforge Ltd (Technology)
Equity, Since 31 May 23 | COFORGE9% ₹1,126 Cr 1,362,525
↓ -77,475 Persistent Systems Ltd (Technology)
Equity, Since 31 Mar 23 | PERSISTENT9% ₹1,084 Cr 1,796,350
↓ -203,650 Polycab India Ltd (Industrials)
Equity, Since 31 Jan 24 | POLYCAB9% ₹1,079 Cr 1,786,833
↓ -13,167 Trent Ltd (Consumer Cyclical)
Equity, Since 31 Jan 23 | 5002519% ₹1,056 Cr 1,835,546
↑ 10,546 Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 30 Sep 23 | KALYANKJIL7% ₹868 Cr 17,250,000 Mahindra & Mahindra Ltd (Consumer Cyclical)
Equity, Since 31 Oct 24 | M&M6% ₹747 Cr 2,500,000
↓ -750,000 Bharti Airtel Ltd (Partly Paid Rs.1.25) (Communication Services)
Equity, Since 30 Apr 24 | 8901575% ₹600 Cr 5,000,000 Cholamandalam Investment and Finance Co Ltd (Financial Services)
Equity, Since 31 Mar 23 | CHOLAFIN5% ₹579 Cr 4,500,000 Bharti Airtel Ltd (Communication Services)
Equity, Since 30 Apr 24 | BHARTIARTL4% ₹488 Cr 3,000,000 CG Power & Industrial Solutions Ltd (Industrials)
Equity, Since 31 Jan 25 | 5000933% ₹413 Cr 6,500,000
↑ 6,500,000 5. Invesco India Mid Cap Fund
CAGR/Annualized return of 16% since its launch. Ranked 38 in Mid Cap category. Return for 2024 was 43.1% , 2023 was 34.1% and 2022 was 0.5% . Invesco India Mid Cap Fund
Growth Launch Date 19 Apr 07 NAV (13 Mar 25) ₹142.37 ↓ -0.84 (-0.59 %) Net Assets (Cr) ₹5,645 on 31 Jan 25 Category Equity - Mid Cap AMC Invesco Asset Management (India) Private Ltd Rating ☆☆ Risk Moderately High Expense Ratio 1.89 Sharpe Ratio 0.82 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 29 Feb 20 ₹10,000 28 Feb 21 ₹13,136 28 Feb 22 ₹15,671 28 Feb 23 ₹16,374 29 Feb 24 ₹24,371 28 Feb 25 ₹26,911 Returns for Invesco India Mid Cap Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 13 Mar 25 Duration Returns 1 Month -4.3% 3 Month -18.7% 6 Month -16.1% 1 Year 17.2% 3 Year 20.3% 5 Year 24.3% 10 Year 15 Year Since launch 16% Historical performance (Yearly) on absolute basis
Year Returns 2024 43.1% 2023 34.1% 2022 0.5% 2021 43.1% 2020 24.4% 2019 3.8% 2018 -5.3% 2017 44.3% 2016 1.1% 2015 6.4% Fund Manager information for Invesco India Mid Cap Fund
Name Since Tenure Aditya Khemani 9 Nov 23 1.31 Yr. Amit Ganatra 1 Sep 23 1.5 Yr. Data below for Invesco India Mid Cap Fund as on 31 Jan 25
Equity Sector Allocation
Sector Value Financial Services 22.9% Consumer Cyclical 20.76% Health Care 16.35% Technology 10.8% Industrials 10.14% Basic Materials 9.5% Real Estate 7.14% Communication Services 1.69% Asset Allocation
Asset Class Value Cash 0.72% Equity 99.28% Top Securities Holdings / Portfolio
Name Holding Value Quantity L&T Finance Ltd (Financial Services)
Equity, Since 31 Dec 23 | LTF4% ₹245 Cr 16,854,973
↑ 3,399,885 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Dec 22 | MAXHEALTH4% ₹238 Cr 2,246,434 The Federal Bank Ltd (Financial Services)
Equity, Since 31 Oct 22 | FEDERALBNK4% ₹234 Cr 12,506,782 Dixon Technologies (India) Ltd (Technology)
Equity, Since 28 Feb 22 | DIXON4% ₹233 Cr 155,335 BSE Ltd (Financial Services)
Equity, Since 31 Dec 23 | BSE4% ₹232 Cr 436,534 Trent Ltd (Consumer Cyclical)
Equity, Since 30 Apr 21 | 5002514% ₹209 Cr 363,079 JK Cement Ltd (Basic Materials)
Equity, Since 31 Oct 22 | JKCEMENT4% ₹208 Cr 431,234
↑ 54,676 Coforge Ltd (Technology)
Equity, Since 31 Mar 22 | COFORGE3% ₹194 Cr 234,918 Max Financial Services Ltd (Financial Services)
Equity, Since 30 Nov 23 | 5002713% ₹188 Cr 1,684,103
↑ 300,918 Prestige Estates Projects Ltd (Real Estate)
Equity, Since 30 Nov 23 | PRESTIGE3% ₹178 Cr 1,305,659 6. UTI Healthcare Fund
CAGR/Annualized return of 14.7% since its launch. Ranked 40 in Sectoral category. Return for 2024 was 42.9% , 2023 was 38.2% and 2022 was -12.3% . UTI Healthcare Fund
Growth Launch Date 28 Jun 99 NAV (13 Mar 25) ₹255.525 ↓ -0.59 (-0.23 %) Net Assets (Cr) ₹1,150 on 31 Jan 25 Category Equity - Sectoral AMC UTI Asset Management Company Ltd Rating ☆ Risk High Expense Ratio 2.38 Sharpe Ratio 1.03 Information Ratio -0.36 Alpha Ratio 0.34 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 29 Feb 20 ₹10,000 28 Feb 21 ₹15,607 28 Feb 22 ₹17,328 28 Feb 23 ₹16,427 29 Feb 24 ₹25,870 28 Feb 25 ₹28,711 Returns for UTI Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 13 Mar 25 Duration Returns 1 Month -3.1% 3 Month -11% 6 Month -11.7% 1 Year 19% 3 Year 18.3% 5 Year 25.4% 10 Year 15 Year Since launch 14.7% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.9% 2023 38.2% 2022 -12.3% 2021 19.1% 2020 67.4% 2019 1.2% 2018 -7.5% 2017 6.2% 2016 -9.7% 2015 12.4% Fund Manager information for UTI Healthcare Fund
Name Since Tenure Kamal Gada 2 May 22 2.83 Yr. Data below for UTI Healthcare Fund as on 31 Jan 25
Equity Sector Allocation
Sector Value Health Care 96.4% Basic Materials 1.35% Asset Allocation
Asset Class Value Cash 2.26% Equity 97.74% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA11% ₹126 Cr 725,000 Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 5000876% ₹69 Cr 464,949 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDY5% ₹57 Cr 470,234 Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | 5323314% ₹50 Cr 186,798
↓ -6,249 Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | 5322964% ₹45 Cr 309,311 Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Dec 20 | PGHL3% ₹40 Cr 74,000 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSP3% ₹38 Cr 56,271
↓ -3,729 Gland Pharma Ltd (Healthcare)
Equity, Since 30 Nov 20 | GLAND3% ₹37 Cr 240,477
↓ -25,829 Krishna Institute of Medical Sciences Ltd (Healthcare)
Equity, Since 30 Jun 21 | 5433083% ₹36 Cr 597,765 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | 5328433% ₹36 Cr 557,701 7. SBI Healthcare Opportunities Fund
CAGR/Annualized return of 15.3% since its launch. Ranked 34 in Sectoral category. Return for 2024 was 42.2% , 2023 was 38.2% and 2022 was -6% . SBI Healthcare Opportunities Fund
Growth Launch Date 31 Dec 04 NAV (13 Mar 25) ₹394.43 ↓ -0.17 (-0.04 %) Net Assets (Cr) ₹3,522 on 31 Jan 25 Category Equity - Sectoral AMC SBI Funds Management Private Limited Rating ☆☆ Risk High Expense Ratio 2.09 Sharpe Ratio 1.36 Information Ratio 0.67 Alpha Ratio 4.66 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 29 Feb 20 ₹10,000 28 Feb 21 ₹15,269 28 Feb 22 ₹16,984 28 Feb 23 ₹16,978 29 Feb 24 ₹27,281 28 Feb 25 ₹30,451 Returns for SBI Healthcare Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 13 Mar 25 Duration Returns 1 Month -2.9% 3 Month -7.7% 6 Month -6.5% 1 Year 20.7% 3 Year 21.7% 5 Year 27.5% 10 Year 15 Year Since launch 15.3% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.2% 2023 38.2% 2022 -6% 2021 20.1% 2020 65.8% 2019 -0.5% 2018 -9.9% 2017 2.1% 2016 -14% 2015 27.1% Fund Manager information for SBI Healthcare Opportunities Fund
Name Since Tenure Tanmaya Desai 1 Jun 11 13.76 Yr. Pradeep Kesavan 31 Dec 23 1.17 Yr. Data below for SBI Healthcare Opportunities Fund as on 31 Jan 25
Equity Sector Allocation
Sector Value Health Care 91.34% Basic Materials 6.85% Asset Allocation
Asset Class Value Cash 1.72% Equity 98.2% Debt 0.08% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA14% ₹488 Cr 2,800,000
↑ 300,000 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 21 | MAXHEALTH7% ₹233 Cr 2,200,000
↑ 200,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB6% ₹218 Cr 390,000
↑ 30,000 Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | 5000875% ₹178 Cr 1,200,000
↓ -200,000 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 23 | 5002575% ₹175 Cr 840,000
↑ 40,000 Lonza Group Ltd ADR (Healthcare)
Equity, Since 31 Jan 24 | LO3A5% ₹165 Cr 300,000 Mankind Pharma Ltd (Healthcare)
Equity, Since 30 Apr 23 | MANKIND4% ₹136 Cr 560,000
↑ 36,984 Jupiter Life Line Hospitals Ltd (Healthcare)
Equity, Since 31 Aug 23 | JLHL4% ₹130 Cr 800,000 Krishna Institute of Medical Sciences Ltd (Healthcare)
Equity, Since 30 Nov 22 | 5433084% ₹128 Cr 2,100,000 Ami Organics Ltd (Basic Materials)
Equity, Since 30 Jun 24 | 5433494% ₹125 Cr 525,000 8. TATA India Pharma & Healthcare Fund
CAGR/Annualized return of 11.5% since its launch. Return for 2024 was 40.4% , 2023 was 36.6% and 2022 was -8% . TATA India Pharma & Healthcare Fund
Growth Launch Date 28 Dec 15 NAV (13 Mar 25) ₹27.3567 ↓ -0.11 (-0.41 %) Net Assets (Cr) ₹1,212 on 31 Jan 25 Category Equity - Sectoral AMC Tata Asset Management Limited Rating Risk High Expense Ratio 0 Sharpe Ratio 0.9 Information Ratio 0.56 Alpha Ratio 2.72 Min Investment 5,000 Min SIP Investment 150 Exit Load 0-3 Months (0.25%),3 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 29 Feb 20 ₹10,000 28 Feb 21 ₹14,904 28 Feb 22 ₹17,032 28 Feb 23 ₹16,283 29 Feb 24 ₹26,062 28 Feb 25 ₹27,619 Returns for TATA India Pharma & Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 13 Mar 25 Duration Returns 1 Month -4.7% 3 Month -10% 6 Month -13.3% 1 Year 12.8% 3 Year 17.3% 5 Year 24.7% 10 Year 15 Year Since launch 11.5% Historical performance (Yearly) on absolute basis
Year Returns 2024 40.4% 2023 36.6% 2022 -8% 2021 19.1% 2020 64.4% 2019 5.5% 2018 -2.6% 2017 4.7% 2016 -14.7% 2015 Fund Manager information for TATA India Pharma & Healthcare Fund
Name Since Tenure Meeta Shetty 9 Mar 21 3.98 Yr. Rajat Srivastava 16 Sep 24 0.45 Yr. Data below for TATA India Pharma & Healthcare Fund as on 31 Jan 25
Equity Sector Allocation
Sector Value Health Care 93.44% Basic Materials 2.22% Asset Allocation
Asset Class Value Cash 4.34% Equity 95.66% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Jan 16 | SUNPHARMA12% ₹140 Cr 804,300 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 18 | DRREDDY7% ₹87 Cr 714,555
↑ 100,000 Aurobindo Pharma Ltd (Healthcare)
Equity, Since 30 Apr 20 | AUROPHARMA7% ₹87 Cr 741,000 Lupin Ltd (Healthcare)
Equity, Since 30 Nov 17 | 5002576% ₹75 Cr 360,240
↓ -50,000 Cipla Ltd (Healthcare)
Equity, Since 30 Apr 20 | 5000876% ₹72 Cr 490,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB5% ₹59 Cr 104,965 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Oct 20 | 5328435% ₹55 Cr 855,100 Zydus Lifesciences Ltd (Healthcare)
Equity, Since 31 Dec 22 | 5323214% ₹46 Cr 471,287 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 31 Dec 16 | APOLLOHOSP3% ₹40 Cr 58,903 Wockhardt Ltd (Healthcare)
Equity, Since 31 Mar 24 | WOCKPHARMA3% ₹39 Cr 274,871 9. IDBI Small Cap Fund
CAGR/Annualized return of 13.3% since its launch. Return for 2024 was 40% , 2023 was 33.4% and 2022 was 2.4% . IDBI Small Cap Fund
Growth Launch Date 21 Jun 17 NAV (13 Mar 25) ₹26.2569 ↓ -0.06 (-0.23 %) Net Assets (Cr) ₹491 on 31 Jan 25 Category Equity - Small Cap AMC IDBI Asset Management Limited Rating Risk Moderately High Expense Ratio 2.3 Sharpe Ratio 0.61 Information Ratio 0.24 Alpha Ratio 11.34 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-12 Months (1%),12 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 29 Feb 20 ₹10,000 28 Feb 21 ₹13,000 28 Feb 22 ₹18,418 28 Feb 23 ₹19,451 29 Feb 24 ₹28,178 28 Feb 25 ₹28,053 Returns for IDBI Small Cap Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 13 Mar 25 Duration Returns 1 Month -7.5% 3 Month -23.4% 6 Month -22.9% 1 Year 13.7% 3 Year 15.8% 5 Year 26.9% 10 Year 15 Year Since launch 13.3% Historical performance (Yearly) on absolute basis
Year Returns 2024 40% 2023 33.4% 2022 2.4% 2021 64.7% 2020 19% 2019 -4.4% 2018 -15% 2017 2016 2015 Fund Manager information for IDBI Small Cap Fund
Name Since Tenure Nikhil Rungta 1 Jul 24 0.67 Yr. Mahesh Bendre 1 Jul 24 0.67 Yr. Data below for IDBI Small Cap Fund as on 31 Jan 25
Equity Sector Allocation
Sector Value Industrials 35.29% Consumer Cyclical 15.69% Basic Materials 13.93% Utility 8.07% Consumer Defensive 6.62% Financial Services 5.66% Health Care 4.38% Technology 3.26% Communication Services 2.92% Real Estate 1.01% Asset Allocation
Asset Class Value Cash 3.16% Equity 96.84% Top Securities Holdings / Portfolio
Name Holding Value Quantity JTL Industries Ltd (Basic Materials)
Equity, Since 31 Jul 24 | 5346003% ₹16 Cr 1,701,359
↑ 278,525 International Gemmological Institute (India) Ltd (Basic Materials)
Equity, Since 31 Dec 24 | IGIL3% ₹15 Cr 303,787
↑ 9,087 Concord Enviro Systems Ltd (Utilities)
Equity, Since 31 Dec 24 | CEWATER3% ₹14 Cr 207,228
↑ 102,234 Sanathan Textiles Ltd (Consumer Cyclical)
Equity, Since 31 Dec 24 | SANATHAN3% ₹13 Cr 375,636
↑ 206,487 Housing & Urban Development Corp Ltd (Financial Services)
Equity, Since 31 Oct 24 | HUDCO3% ₹13 Cr 553,477
↑ 225,390 Navkar Corp Ltd (Industrials)
Equity, Since 31 Jul 24 | 5393323% ₹12 Cr 1,008,833
↑ 420,515 Himatsingka Seide Ltd (Consumer Cyclical)
Equity, Since 31 Oct 24 | 5140433% ₹12 Cr 772,695
↑ 226,995 Shakti Pumps (India) Ltd (Industrials)
Equity, Since 31 Mar 24 | SHAKTIPUMP2% ₹11 Cr 118,679
↓ -5,406 Allied Blenders and Distillers Ltd (Consumer Defensive)
Equity, Since 31 Jul 24 | ABDL2% ₹11 Cr 286,201
↑ 42,054 Manorama Industries Ltd (Consumer Defensive)
Equity, Since 31 Dec 24 | 5419742% ₹11 Cr 102,604
↑ 21,667 10. L&T Midcap Fund
CAGR/Annualized return of 18.2% since its launch. Ranked 5 in Mid Cap category. Return for 2024 was 39.7% , 2023 was 40% and 2022 was 1.1% . L&T Midcap Fund
Growth Launch Date 9 Aug 04 NAV (13 Mar 25) ₹312.188 ↓ -1.64 (-0.52 %) Net Assets (Cr) ₹10,753 on 31 Jan 25 Category Equity - Mid Cap AMC L&T Investment Management Ltd Rating ☆☆☆☆ Risk High Expense Ratio 1.77 Sharpe Ratio 0.53 Information Ratio -0.14 Alpha Ratio 4.43 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 29 Feb 20 ₹10,000 28 Feb 21 ₹12,679 28 Feb 22 ₹14,469 28 Feb 23 ₹15,177 29 Feb 24 ₹23,247 28 Feb 25 ₹23,245 Returns for L&T Midcap Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 13 Mar 25 Duration Returns 1 Month -5.7% 3 Month -25% 6 Month -22.6% 1 Year 4.6% 3 Year 17.1% 5 Year 21.2% 10 Year 15 Year Since launch 18.2% Historical performance (Yearly) on absolute basis
Year Returns 2024 39.7% 2023 40% 2022 1.1% 2021 30.4% 2020 19% 2019 -0.2% 2018 -12% 2017 52.3% 2016 9.8% 2015 10.8% Fund Manager information for L&T Midcap Fund
Name Since Tenure Venugopal Manghat 1 Oct 23 1.42 Yr. Cheenu Gupta 26 Nov 22 2.26 Yr. Sonal Gupta 1 Oct 23 1.42 Yr. Data below for L&T Midcap Fund as on 31 Jan 25
Equity Sector Allocation
Sector Value Industrials 25.79% Financial Services 20.07% Technology 18.12% Consumer Cyclical 12.9% Health Care 8.52% Utility 4.66% Real Estate 4.66% Consumer Defensive 2.39% Basic Materials 1.96% Communication Services 0.06% Asset Allocation
Asset Class Value Cash 0.86% Equity 99.14% Top Securities Holdings / Portfolio
Name Holding Value Quantity CG Power & Industrial Solutions Ltd (Industrials)
Equity, Since 31 May 24 | 5000935% ₹541 Cr 8,521,430 Persistent Systems Ltd (Technology)
Equity, Since 30 Nov 22 | PERSISTENT5% ₹499 Cr 827,298
↑ 336,498 PB Fintech Ltd (Financial Services)
Equity, Since 31 Jan 24 | 5433905% ₹494 Cr 2,860,900
↑ 141,700 BSE Ltd (Financial Services)
Equity, Since 30 Apr 24 | BSE5% ₹493 Cr 929,058
↑ 181,258 Dixon Technologies (India) Ltd (Technology)
Equity, Since 30 Apr 24 | DIXON4% ₹457 Cr 304,800 Zomato Ltd (Consumer Cyclical)
Equity, Since 31 Mar 24 | 5433204% ₹388 Cr 17,596,500
↑ 2,460,941 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 30 Sep 21 | MAXHEALTH4% ₹387 Cr 3,648,000
↑ 305,000 HDFC Asset Management Co Ltd (Financial Services)
Equity, Since 31 Dec 22 | HDFCAMC3% ₹373 Cr 964,400 Indian Hotels Co Ltd (Consumer Cyclical)
Equity, Since 30 Apr 18 | 5008503% ₹366 Cr 4,782,177
↑ 1,645,877 Trent Ltd (Consumer Cyclical)
Equity, Since 30 Jun 19 | 5002513% ₹365 Cr 634,900
ഇവിടെ നൽകിയിരിക്കുന്ന വിവരങ്ങൾ കൃത്യമാണെന്ന് ഉറപ്പാക്കാൻ എല്ലാ ശ്രമങ്ങളും നടത്തി. എന്നിരുന്നാലും, ഡാറ്റയുടെ കൃത്യത സംബന്ധിച്ച് ഒരു ഉറപ്പുമില്ല. നിക്ഷേപം നടത്തുന്നതിന് മുമ്പ് ദയവായി സ്കീം വിവര പ്രമാണം ഉപയോഗിച്ച് പരിശോധിക്കുക.
AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153
Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.
©2025 Shepard Technologies Private Limited. All Rights Reserved